also, not talking the pps drop but the news today should be
also, not talking the pps drop but the news today should be expectedand probably answers one of our questions.
the comprehensive update said AMBS would give away all is AVDX shares. when we announced the reacquisition of the diagnostics and recieving 30M AVDX shares, we weren't sure if we'd sign the tender and then close the diagnostic deal, thereby keeping 30M shares for ourselves, or if they lenders would also get those 30M
it should be clear now that lenders want those 30M shares too. we're getting 45 extra days of freedom for it, and we'll still keep the assets
1
Amarantus Bioscience Holdings (AMBS) Stock Research Links
Scroll down for more posts ▼
Top 10 Most Recent News Articles
Top 5 Most Recently Viewed Articles
Revolutionizing Your Cornhole Experience Cornhole has become a staple game at gatherings and tailgates, bringing people together for fun and competition. As gameplay evolves, so too do the accessories that enhance the experience. An innovative inventor has recently introduced a new accessory designed specifically for cornhole players, aiming to alleviate some of the...
Continue Reading
ManpowerGroup and Junior Achievement Launch Career Exploration Initiative In an effort to enhance educational experiences for young people, ManpowerGroup (NYSE: MAN) has partnered with Junior Achievement (JA) to introduce a cutting-edge career exploration initiative. This collaboration marks a significant advancement in engaging students and providing them with the...
Continue Reading
Oportun Set to Release Third Quarter Financial Results Oportun, a forward-thinking financial services company, is all set to announce its financial outcomes for the third quarter of the upcoming year. This release is scheduled for November 4, after the market closes, and it marks a significant moment for the company and its investors. Conference Call and Webcast Details...
Continue Reading
ASEAN Point of Care Diagnostics Market Growth Overview The ASEAN Point of Care Diagnostics Market is witnessing impressive growth, expected to surge from approximately $1.05 billion in 2024 to an estimated $1.36 billion by 2030, with a robust CAGR of 4.7%. The demand for these diagnostics is largely driven by an increased incidence of chronic conditions such as diabetes,...
Continue Reading
Microsoft Versus Its Competitors in Software Industry In the ever-evolving and competitive world of technology, conducting thorough evaluations of companies is essential for investors and enthusiasts alike. This article presents an in-depth comparison, taking a closer look at Microsoft (MSFT) and how it stands against its vital competitors in the software sector. We...
Continue Reading